Prescription drug · ANDA
Primidone NDC 55111-477
Primidone 50 mg/1 · Tablet · Oral · Dr. Reddy's Laboratories Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55111-477-01 | 55111047701 | 100 TABLET in 1 BOTTLE (55111-477-01)Marketed from Oct 3, 2008 | |
| 55111-477-05 | 55111047705 | 500 TABLET in 1 BOTTLE (55111-477-05)Marketed from Oct 3, 2008 | |
| 55111-477-30 | 55111047730 | 30 TABLET in 1 BOTTLE (55111-477-30)Marketed from Oct 3, 2008 | |
| 55111-477-60 | 55111047760 | 60 TABLET in 1 BOTTLE (55111-477-60)Marketed from Oct 3, 2008 | |
| 55111-477-78 | 55111047778 | 10 BLISTER PACK in 1 CARTON (55111-477-78) / 10 TABLET in 1 BLISTER PACK (55111-477-79)Marketed from Oct 3, 2008 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Primidone
- Generic name (nonproprietary)
- primidone
- Active ingredients
- Primidone — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040862
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 55111-477_6f5c36d3-3f99-803c-5be6-66b2e1058946SPL ID 6f5c36d3-3f99-803c-5be6-66b2e1058946SPL set ID a4f917f4-2aa2-c3ed-071e-232fa0f125e8RxCUI 96304, 198150UNII 13AFD7670Q
- Pharmacologic class
- Anti-epileptic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455111047701followed by a unit qualifier and the quantityPackage 55111-0477-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Primidone tablets, used alone or concomitantly with other anticonvulsants, are indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040862
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Primidone | Primidone 250 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | 55111-476 |